Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation

There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester af...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Meghan G., Sekhon, Mehtab K., Reed, Kathryn L., Anderson, Caroline F., Borjon, Nydia D., Tardiff, Jil C., Barber, Brent J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655206/
https://www.ncbi.nlm.nih.gov/pubmed/26337809
http://dx.doi.org/10.1007/s00246-015-1250-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655206/
https://www.ncbi.nlm.nih.gov/pubmed/26337809
http://dx.doi.org/10.1007/s00246-015-1250-1

Ejemplares similares